News
MarketBeat on MSN6d
Viking Therapeutics Stock May Struggle After As-Expected ReportCompanyOverview|NASDAQ:VKTX] Viking Therapeutics Inc. (NASDAQ: VKTX) reported earnings after the market closed on Apr. 23.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company’s lead drug candidate is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback